“It is our responsibility to bring a legitimate and serious educational response to... an issue that is straining many municipalities, state agencies and police and other public safety officials.”
A recent cannabis and opioid study highlighted that “corporate actors” with “deep pockets have substantial ability to promote congenial results, as suffering people are desperate for effective solutions.”
MPP’s new executive director talks equity, federal legalization, and the organization’s role in the booming, multibillion dollar global cannabis industry.
A presidential candidate says ending prohibition is the heart of the matter, and that other reforms, like criminal justice, would follow. She hopes for bipartisan support.
Q&A: After a survey shows a hunger for answers among clinicians and patients alike, a foundation gathers experts to chart a research path. Here’s why.
In an exclusive interview, US Attorney Billy Williams weighs in on banking, hemp, overproduction, illicit-market diversion—and cannabis regulators who fail to think things out.
New York Senator Diane Savino, an architect of the state’s medical-cannabis law, has plenty to say about the governor’s ideas for recreational legalization.
The Research Director of UCLA's Cannabis Research Initiative talks opioids, how men and women experience cannabis differently, and Alex Berenson's misrepresentation of cannabis research.
Josh Hovey shares the Michigan Cannabis Industry Association’s plans to work with the Democratic administration tasked with bringing medical and recreational use sales above board.
Nikki Fried, a former medical cannabis lobbyist and the state’s new Commissioner of Agriculture, tells Cannabis Wire how she plans to use her office to widen access to medical cannabis.
Adult-use legalization is expected in Illinois in 2019. The prospective bill’s primary House sponsor tells Cannabis Wire she’s aiming to pass model progressive legislation.